Regeneron Pharmaceuticals, Inc. Portfolio Stock Holdings
Regeneron Pharmaceuticals, Inc. disclosed 2 stock positions valued at approximately $47.9 million in its latest SEC 13F filing. The largest holdings include Intellia Therapeutics, Inc. and Adicet Bio, Inc.. The filing reflects positions held as of March 31, 2026 and was filed on May 8, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 2
- Portfolio Value
- $47.9M
Holdings by Sector